Red Arrow Therapeutics raised $4.5M Seed funding round

Red Arrow Therapeutics raised $4.5M Seed funding round

Red Arrow Therapeutics Inc. has successfully closed a seed extension round, securing $4.5 million from four prestigious Japan-based institutional investors. This brings the total funding raised by the company to approximately $5.5 million, with previous funding from The University of Tokyo Edge Capital Partners Co., Ltd., SkyDeck, an accelerator affiliated with the University of California, Berkeley, and other sources. Investment is also involved. Poor funding.

Founded in 2021 as a spin-off from the University of Tokyo's Cabral Lab, Red Arrow Therapeutics Inc. pH Sensing specializes in the development of nanomedicine drug delivery technologies, with a focus on various therapeutic areas, including oncology. Based in Boston, Massachusetts, the company is dedicated to advancing innovative technology to meet the needs of patients worldwide.

Funds from the seed extension round will facilitate pivotal clinical studies to assess the safety and efficacy of the company's lead compound, IL-12-loaded nanopolymeric micelles. Additionally, the investment will support the start-up of manufacturing activities through collaboration with external partners.

About the Author

Leave a Reply